David Meltzer to Drug Approval
This is a "connection" page, showing publications David Meltzer has written about Drug Approval.
Connection Strength
0.410
-
Risks and benefits of risk-management plans. Health Aff (Millwood). 2007 May-Jun; 26(3):681-3.
Score: 0.290
-
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatments. Adv Health Econ Health Serv Res. 2012; 23:123-48.
Score: 0.100
-
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy. 2008 Dec; 28(12):1443-52.
Score: 0.020